02.02.2013 Views

Internal consistency of risk free rate and MRP in the CAPM

Internal consistency of risk free rate and MRP in the CAPM

Internal consistency of risk free rate and MRP in the CAPM

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

8. Conclusion<br />

181. There is unambiguous evidence that <strong>risk</strong> premiums <strong>in</strong> <strong>the</strong> market for funds have risen<br />

to <strong>of</strong>fset <strong>the</strong> recent fall <strong>in</strong> CGS yields. The effect <strong>of</strong> this is that <strong>the</strong> prevail<strong>in</strong>g cost <strong>of</strong><br />

equity is at least as high as under normal market conditions – notwithst<strong>and</strong><strong>in</strong>g that <strong>the</strong><br />

CGS yields are at 50 year lows. In <strong>the</strong>se circumstances, it would be an error to<br />

estimate <strong>the</strong> cost <strong>of</strong> equity us<strong>in</strong>g prevail<strong>in</strong>g CGS yields <strong>in</strong> comb<strong>in</strong>ation with a historical<br />

average estimate <strong>of</strong> <strong>the</strong> market <strong>risk</strong> premium.<br />

182. Alternative methodologies consistent with Rule 87(1) <strong>of</strong> <strong>the</strong> NGR <strong>and</strong> section 24(2)<br />

<strong>and</strong> (5) <strong>of</strong> <strong>the</strong> NGL <strong>in</strong>volve estimat<strong>in</strong>g <strong>the</strong> cost <strong>of</strong> equity us<strong>in</strong>g:<br />

i. A DGM estimate <strong>of</strong> <strong>the</strong> cost <strong>of</strong> equity for firms which experience <strong>risk</strong>s that are<br />

comparable to those confronted by firms which provide <strong>the</strong> reference services.<br />

ii. DGM estimates <strong>of</strong> <strong>the</strong> cost <strong>of</strong> equity for <strong>the</strong> market portfolio ( ) <strong>and</strong> a<br />

sepa<strong>rate</strong> process for estimat<strong>in</strong>g <strong>the</strong> adjustment for differences <strong>in</strong> <strong>risk</strong> between <strong>the</strong><br />

market <strong>and</strong> <strong>the</strong> reference services (a beta different to 1.0).<br />

iii. Estimate a ‘normal’ level for <strong>the</strong> cost <strong>of</strong> equity for <strong>the</strong> reference services <strong>and</strong> make<br />

an adjustment to that based on evidence/proxies that suggest<br />

heightened/depressed prevail<strong>in</strong>g conditions <strong>in</strong> <strong>the</strong> market for funds relative to<br />

‘normal’ conditions.<br />

183. Any <strong>of</strong> <strong>the</strong>se approaches will, <strong>in</strong> my view, result <strong>in</strong> an estimate <strong>of</strong> <strong>the</strong> cost <strong>of</strong> equity that<br />

is at least 10.58%. This is around 2% more than is estimated us<strong>in</strong>g prevail<strong>in</strong>g CGS<br />

yields <strong>in</strong> conjunction with <strong>the</strong> AER’s most recently used estimates <strong>of</strong> <strong>the</strong> <strong>MRP</strong> (6%)<br />

<strong>and</strong> equity beta (0.8) estimates.<br />

Competition Economists Group<br />

www.CEG-AP.COM<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!